The Chinese Solar Machine Layer by Layer Fire in the Library The Mystery Behind Anesthesia
Smaller implants: Scientists are developing a smaller version of the electrocorticography (ECoG) device shown here as a neural interface for patients with paralysis. ECoG, in which an array of electrodes records neural activity from the surface of the brain, is currently used to find the source of seizures in patients with uncontrolled epilepsy.
Eric Leuthardt, Washington University School of Medicine
A startup aims to develop a minimally invasive neural prosthesis for disabled patients.
A technology currently used to monitor epilepsy is being adapted into a neural interface for people who are paralyzed or have motor impairments from neurodegenerative disease. Neurolutions, a startup based in St. Louis, is developing a small, implanted device that translates signals recorded from the surface of the brain into computer commands.
The device is based on electrocorticography (ECoG), in which a grid of electrodes is surgically placed directly on the surface of the brain to monitor electrical activity. This technology is currently used for surgical planning in patients with uncontrolled epilepsy in order to find the origin of their seizures. But Eric Leuthardt and Dan Moran at Washington University School of Medicine, in St. Louis, and Gerwin Schalk at the Wadsworth Center, in Albany, NY, are developing a much smaller version that would be implanted long term to allow paralyzed patients to control a computer and perhaps prosthetic limbs and other devices.
"We're extremely excited about these signals because they are really opening a whole new avenue for extracting information from the brain in humans," says Schalk. "The nice thing about ECoG is that it targets a space that no other sensor technology has been in before."
Most efforts to build neural interfaces have focused on either electroencephalography (EEG), a noninvasive technology that records electrical activity from the scalp, or electrodes implanted into the brain. ECoG represents an intermediate between the two: because it records directly from the brain, it can provide a higher level of control than EEG, which is susceptible to distortion as the signal travels through the skull and as the patient moves. In addition, ECoG's position on the surface of the brain may present fewer health issues than electrodes that penetrate brain tissue.
Because ECoG is used in epilepsy patients, researchers have already been able to conduct proof of principle experiments on a much wider scale than has been done using other invasive technologies. Tests of more than 20 patients have shown that people can quickly learn to move a cursor on a computer screen using their brain activity. Researchers first ask patients to imagine performing a certain action, such as moving a computer cursor to the left. They then identify changes in the frequency of electrical signals that correlate with that movement and use those to control the computer. The patient learns to more precisely control his or her brain activity and hence more reliably performs the task within half an hour.
"With minimal learning efforts, we have been able to tune and train the system to recognize simple commands, like 'up,' and 'down,' and 'left' and 'right,'" says Shawn Lunney, Neurolutions' chief executive officer. Lunney estimates that patients can control a computer cursor with approximately 80 percent accuracy.
"With the results from our studies, it made sense to develop the company and the intellectual property in parallel with a true next-generational implant," says Leuthardt, a neurosurgeon and former TR100 winner who is continuing his studies in patients. He hopes to show that they can achieve three-dimensional control, which would be required for the most basic control of a prosthetic arm.
Epicortical signal registration has many advantages as the article clearly states.
It provides a very clear field signal (much better than the EEG) and is less invasive than a deep brain electrode insertion. Furthermore, it's a method where scientists and clinicians have many years of experience from epileptic patients undergoing surgical evaluation.
I believe Neurolutions is in the right direction for a successful commercial solution. More research is probably needed. As far as I know, at least since 2003 another group has been investigating in this field. It's the BMI Initiative at Freiburg University, Germany.
Manufacturing in the United States is in trouble. That's bad news not just for the country's economy but for the future of innovation.
menexis
2 Comments
device
It is absolutely incredible how fast we are progressing. To be able to use a device that translates signals recorded from the surface of the brain into computer is amazing.
Reply
briang1621
173 Comments
Re: device
I agree I love this stuff. If at some point we have the option of going cyborg I would seriously think about it! Unfortunately, even simple voice control technology stink, so I think we have a ways to go before the Cyborg option.
I really hope this technology get approved for paraplegic, it would really help them a lot!
Dr. Brian Glassman
Ph.D Innovation Management from Purdue University
Commercialization
Reply
Amir_Motevakel
1 Comment
Re: device
That's true, although these technologies are really astonishing, still there is along way to go. I'm so interested in this field and I think there is a bottle neck toward which is AI. So more researches need to be done in this field to make these technologies reliable and practical.
Reply